Conference LibraryGated
Orbital Therapeutics · in vivo RNA delivery (acquired by BMS)
Orbital Therapeutics · in vivo RNA/cell engineering 公司 · 2025 被 BMS 以 $1.5B 收购(per OPORD-002 verify priority list)。对 SunVax 的对标: delivery modality 接近(若 LNP/mRNA-based)· therapeutic vs platform business model 不同。
- Type
- company
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- B
- category
- in_vivo_delivery_rna
- status
- draft
- instance_tag
- sunvax-antibody-2025
- platform_tech
- in vivo RNA delivery · cell engineering
- acquisitions
- [object Object]
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.